Manila Bulletin
FDA authorizes 4 COVID-19 vaccines as booster shots
The Food and Drug Administration (FDA) has authorized four COVID-19 vaccine brands – Pfizer-BioNTech, AstraZeneca, and Sinovac – to be used as homologous (same brand) additional doses.
Sputnik Light, however, was approved as a heterologous (different brand) additional dose.
The FDA's recommendation for additional doses specifically targets individuals at high risk, including healthcare professionals, senior citizens, and those with immunocompromised conditions.
Fully-vaccinated healthcare workers can begin receiving these additional doses starting November 17.
The Department of Health (DOH) had previously requested the FDA to evaluate various vaccine combinations for both primary and booster doses.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines commenced the inoculation of fully-vaccinated healthcare workers with COVID-19 booster shots on November 17, 2021.
+1
Read more →
Frontline healthcare workers in the Philippines can now select their preferred COVID-19 vaccine brand for their booster shots, whether it matches their primary series or is a different brand.
+1
Read more →
As of November 18, a total of 6,457 healthcare workers in the Philippines have received their COVID-19 booster shots.
Read more →
The Philippine Food and Drug Administration (FDA) is aiming to grant full marketing authorization for several COVID-19 vaccines by the first quarter of 2022.
Read more →
The Philippine FDA approved on Nov. 17 the country's coronavirus disease (COVID-19) vaccine mix-and-match trials.
+1
Read more →